PGP and cancer: Noteworthy, the potent antiproliferative activity of this compound was maintained in MDR cancer cells, namely paclitaxel-resistant ovarian (A2780T) and lung cancer (A549T) cells, as well as adriamycin-resistant human breast, and P-gp-overexpressed MCF-7 (MCF-7/AD) cancer cell lines.